GSA Capital Partners’s Capricor Therapeutics CAPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-18,243
| Closed | -$252K | – | 1685 |
|
|
2024
Q4 | $252K | Buy |
+18,243
| New | +$252K | 0.02% | 1304 |
|
|
2024
Q3 | – | Sell |
-27,330
| Closed | -$130K | – | 1622 |
|
|
2024
Q2 | $130K | Buy |
+27,330
| New | +$130K | 0.01% | 1504 |
|
|
2024
Q1 | – | Sell |
-32,970
| Closed | -$161K | – | 1635 |
|
|
2023
Q4 | $161K | Sell |
32,970
-10,835
| -25% | -$52.9K | 0.01% | 1361 |
|
|
2023
Q3 | $150K | Buy |
43,805
+25,915
| +145% | +$88.7K | 0.01% | 1341 |
|
|
2023
Q2 | $86K | Buy |
+17,890
| New | +$86K | 0.01% | 1389 |
|
|
2021
Q4 | – | Sell |
-96,632
| Closed | -$388K | – | 1436 |
|
|
2021
Q3 | $388K | Sell |
96,632
-15,732
| -14% | -$63.2K | 0.04% | 853 |
|
|
2021
Q2 | $576K | Buy |
112,364
+98,043
| +685% | +$503K | 0.06% | 541 |
|
|
2021
Q1 | $67K | Sell |
14,321
-64,770
| -82% | -$303K | 0.01% | 1019 |
|
|
2020
Q4 | $271K | Buy |
+79,091
| New | +$271K | 0.04% | 798 |
|